When.com Web Search

  1. Ads

    related to: medlineplus.gov meds

Search results

  1. Results From The WOW.Com Content Network
  2. MedlinePlus - Wikipedia

    en.wikipedia.org/wiki/MedlinePlus

    MedlinePlus is an online information service produced by the United States National Library of Medicine. The service provides curated consumer health information in English and Spanish with select content in additional languages.

  3. Methylphenidate - Wikipedia

    en.wikipedia.org/wiki/Methylphenidate

    The study involved 108 people who inject drugs and 88% of them had injected methylphenidate within the last 30 days and for 63% of them, methylphenidate was the most preferred substance. Treatment of ADHD by way of methylphenidate has led to legal actions, including malpractice suits regarding informed consent , inadequate information on side ...

  4. Levetiracetam - Wikipedia

    en.wikipedia.org/wiki/Levetiracetam

    Levetiracetam was approved for medical use in the United States in 1999 [8] and is available as a generic medication. [13] In 2022, it was the 123rd most commonly prescribed medication in the United States, with more than 5 million prescriptions. [14] [15] It is on the World Health Organization's List of Essential Medicines. [16]

  5. Amlodipine - Wikipedia

    en.wikipedia.org/wiki/Amlodipine

    Amlodipine, sold under the brand name Norvasc among others, is a calcium channel blocker medication used to treat high blood pressure, coronary artery disease (CAD) [10] and variant angina (also called Prinzmetal angina or coronary artery vasospasm, among other names). [11]

  6. Raloxifene - Wikipedia

    en.wikipedia.org/wiki/Raloxifene

    Raloxifene, sold under the brand name Evista among others, is a medication used to prevent and treat osteoporosis in postmenopausal women and those on glucocorticoids. [6] For osteoporosis it is less preferred than bisphosphonates. [6]

  7. Tolmetin - Wikipedia

    en.wikipedia.org/wiki/Tolmetin

    Although the mechanism of action of tolmetin is unknown, research involving humans and animals has shown that tolmetin does not achieve anti-inflammatory response by stimulation of the adrenal or pituitary gland, but it has shown tolmetin restrains prostaglandin synthetase in vitro and reduces plasma levels of prostaglandin E, possibly causing the anti-inflammatory response.